PRTN3 and dementia: PRTN3 was lower in symptomatic AD (AD pathology diagnosis and dementia) compared to controls and asymptomatic AD (AD pathology diagnosis without dementia) in the Mayo Clinic temporal cortex data (not present in the Mount Sinai Brain Bank analysis).